COMBACTE-MAGNET launches

COMBACTE-MAGNET (Combatting Bacterial Resistance in Europe – Molecules against Gram-Negative Infections), a project of the Institutes for Innovative Medicines (IMI) antimicrobial resistance research program New Drugs 4 Bad Bugs (ND4BB) launched this month. The seven-year, €167million project brings together 33 academic and 5 pharmaceutical partners in a collaboration to prevent and treat infections caused by multi-drug resistant bacteria, which are responsible for approximately 25,000 deaths in the EU each year. Professor Leonhard Held leads the EBPI team participating in this project.
More information can be found here...

Walter Schmid

News